Long-term Safety in Atrial Fibrillation Patients

Completed

Phase 2 Results

Summary of Purpose

The purpose of this study is to provide safety and tolerability data for AZD0837 during long-term treatment (5 years) in patients with non-valvular atrial fibrillation (AF) and one or more additional risk factors for stroke and systemic embolic events (moderate to high risk patients).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 March 2012.

1 Oct 2007 19 Mar 2008 1 May 2009 1 May 2009 1 Mar 2012 30 Jun 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

Not available